ImmunOs Therapeutics AG Employee Directory

Biotechnology ResearchZurich, Switzerland11-50 Employees

ImmunOs Therapeutics AG is a biotechnology company focused on developing immunotherapies that engage the innate immune system to treat cancer and autoimmune diseases. Its portfolio comprises novel immunomodulatory proteins that aim to both exert anti-tumor effects and remodel the tumor microenvironment to enhance the activity of existing immunotherapies. The company operates in the biotechnology research sector, pursuing therapies that target key immunoregulatory receptors.

Based in Schlieren, within the Zurich region, ImmunOs Therapeutics advances its pipeline through early clinical development. The lead program, iosH2, is a multi-functional fusion protein designed to block specific LILRB receptors, with potential to act as monotherapy or in combination with checkpoint inhibitors and costimulatory agonists. A recent development includes expanding the Phase I trial of IOS-1002 in combination with Keytruda for solid tumors.

Sign up for free to view info

Company overview Email format